ArticleInfectious agents and cancer2026
Dengue virus infection and potential association with acute lymphoblastic leukemia in Egypt: a pilot study.
Article in Infectious agents and cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesDengue fever is arthropod born disease transmitted by the bite of a mosquito called Aedes aegypti. Some researchers have suggested a link between previous dengue infection and leukemia. The aim of this pilot study is to determine the frequency of dengue infection in acute lymphoblastic leukemia patients (ALL) compared to age and sex matched controls and to find the impact of this infection on the disease outcome. PATIENTS AND
methodsThis is a single center pilot study that included two groups, 30 newly diagnosed pediatric ALL patients and 22 newly diagnosed adult ALL patients that were compared with 50 age and sex matched healthy controls (25 for each group) and 8 pediatric immunosuppressed controls. ELISA was used to detect IgM and IgG antibodies in serum samples at presentation and clinical and laboratory data at admission were collected. Positive and negative dengue patients were followed up for a minimum of six months (hybrid case control –cohort study).
resultsAmong pediatric patients who were evaluated for dengue infection by the serological tests, 46.7% (14/30), 8% (2/25) and 0% (0/8) tested positive for IgG in patients, immuno-competent and immunocompromised controls respectively (p value 0.002). There was a significant association between acute dengue infection and BCR-ABL fusion oncogenic gene only in pediatric patients. No statistically significant difference in short term outcomes was observed.
conclusionThis pilot study provides preliminary data to guide large scale research on the role of dengue infection as a predisposing or exacerbating factor in genetically susceptible children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.